Predictive Oncology Files 8-K: Material Agreement & Equity Sales

Ticker: AGPU · Form: 8-K · Filed: Jul 8, 2025 · CIK: 1446159

Sentiment: neutral

Topics: material-agreement, equity-sale, filing

Related Tickers: POAI

TL;DR

POAI filed an 8-K on July 8th detailing a material agreement from July 1st and equity sales.

AI Summary

Predictive Oncology Inc. entered into a material definitive agreement on July 1, 2025. The company also reported on unregistered sales of equity securities and filed financial statements and exhibits. The filing was made on July 8, 2025.

Why It Matters

This 8-K filing indicates significant corporate activity, including a new material agreement and equity transactions, which could impact the company's financial standing and future operations.

Risk Assessment

Risk Level: medium — The filing involves material agreements and unregistered equity sales, which can introduce financial and regulatory risks.

Key Players & Entities

FAQ

What is the nature of the material definitive agreement entered into by Predictive Oncology Inc. on July 1, 2025?

The filing does not specify the details of the material definitive agreement, only that one was entered into on July 1, 2025.

What type of equity securities were sold in the unregistered sales reported?

The filing mentions unregistered sales of equity securities but does not provide specific details about the type or amount of securities sold.

When was the 8-K filing submitted to the SEC?

The 8-K filing was submitted on July 8, 2025.

What were the previous names of Predictive Oncology Inc.?

Predictive Oncology Inc. was formerly known as Precision Therapeutics Inc. (name change 20180314 and 20180208) and Skyline Medical Inc. (name change 20130807).

What is the primary business of Predictive Oncology Inc. according to its SIC code?

Predictive Oncology Inc.'s Standard Industrial Classification (SIC) code is 3842, which pertains to Orthopedic, Prosthetic & Surgical Appliances & Supplies.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on July 8, 2025 regarding Predictive Oncology Inc. (AGPU).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing